Dyadic Raises $2.9M in Direct Offering Amid Cash Crunch
DYAI sits 30% above its 52-week low of $0.655.
Summary
Dyadic International raised $2.9 million through a registered direct offering and concurrent private placement. The company's Q2 10-Q, filed yesterday, showed cash reserves of just $4.8 million and a going concern warning, so this raise is critical for near-term survival. The offering is dilutive at a market cap of roughly $32 million, but the terms were not disclosed. This follows the company's recent Nasdaq compliance resolution and ongoing ATM program. The capital injection likely extends the runway by a couple of quarters, but the company still needs to demonstrate commercial traction.
At the time of this announcement, DYAI was trading at $0.85 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $32.1M. The 52-week trading range was $0.65 to $1.60. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.